Table 1.
Group No. | Animal No. | Haplotype Mismatch | 1°/2° Skin Transplant† | HSC Engraftment | Skin Survival (Postoperative Day) |
---|---|---|---|---|---|
1 | 13476 | CD→AD | 2° | Yes | Rejected (d55) |
16626 | AC→AD | 2°* | Yes | Rejected (d64) | |
2 | 17468 | AC→AD | 1° | Yes | Survival (>d46) |
17469 | AC→AD | 1° | Yes | Survival (>d300) | |
3 | 17476 | DD→AC | 2° | No | Rejected (d8) |
17506 | DD→AC | 2° | No | Rejected (d7) | |
4 | 17519 | AC→AD | 1° | No | Rejected (d6) |
17520 | AC→AD | 1°* | No | Rejected (d6) |
Topical 0.1% FK506 ointment applied daily in attempt to delay rejection.
1° refers to primarily vascularized skin flap; 2° refers to skin grafts that are secondarily vascularized after placement.